MVS Pharma GmbH Launches MVS Omega-3: A New Standard in Fish Oil Supplementation

Germany — 18.02.2026

MVS Pharma GmbH today announces the official launch of MVS Omega-3, an advanced marine omega-3 supplement developed to address one of the most persistent challenges in the global fish oil market: oxidation, stability, and inconsistent product quality over time.

With demand for omega-3 supplements continuing to grow worldwide, industry scrutiny has intensified around issues of rancidity, variable bioavailability, and packaging systems that fail to protect highly sensitive marine lipids from oxygen, light, and heat exposure. MVS Omega-3 was developed as a direct response to these concerns.

Engineering Stability as the Core Principle

Omega-3 fatty acids (EPA and DHA) are biologically valuable but chemically fragile. Repeated exposure to air and environmental factors can accelerate degradation, affecting freshness, sensory properties, and overall quality.

Rather than focusing solely on higher milligram claims, MVS Pharma designed MVS Omega-3 around total stability control — from sourcing to the moment of intake.

MVS Omega-3 features:

• Over 90% pure omega-3 fatty acids
• 92% re-esterified triglyceride (rTG) form for enhanced bioavailability
• 758 mg EPA and 362 mg DHA per serving (2 capsules)
• Full TOTOX (Total Oxidation) monitoring across production, encapsulation, storage, and transport
• Certified and traceable raw materials
• Independent third-party laboratory verification

First-of-Its-Kind Dual Protection System

A defining innovation of MVS Omega-3 is its dual-layer inert-gas packaging system, where each capsule is individually sealed in a protected environment.

Traditional bulk bottles expose all capsules to shared air space and repeated opening. In contrast, MVS Omega-3 ensures:

• Individual capsule sealing
• No shared air exposure
• Protection from light and environmental stressors until the moment of use

This design principle ensures that the first capsule and the last capsule are equally protected, addressing a long-standing gap in supplement packaging standards.

Developed Under Pharmaceutical Supervision

MVS Omega-3 is developed, produced, and packaged under a fully licensed pharmaceutical quality system, with documented and audited processes across:

• Raw material sourcing
• Encapsulation validation
• Controlled storage
• GDP-aligned transport protocols

Oil quality is confirmed by globally recognized reference laboratories, and production is conducted under certified supervision.

Raising the Industry Standard

“Our goal was not to create another omega-3 supplement, but to re-engineer how omega-3 stability is protected,” said a spokesperson for MVS Pharma GmbH. “Consumers deserve transparency, verified quality, and a system that safeguards freshness from production to final intake. MVS Omega-3 represents a shift from marketing claims to measurable quality control.”

By integrating formulation purity, oxidation prevention, bioavailability optimization, and advanced packaging technology, MVS Omega-3 establishes what the company describes as a new golden standard in fish oil supplementation.

Availability

MVS Omega-3 is now available for order via MVS Pharma GmbH’s official distribution channels.

About MVS Pharma GmbH

MVS Pharma GmbH is a Germany-based pharmaceutical and life-science company focused on evidence-driven product development, quality management excellence, and advanced formulation technologies. The company is committed to transparency, traceability, and scientifically grounded innovation in preventive health solutions.

For media inquiries, interviews, or additional information, please contact:

Media Relations
Mihaela Ahchieva; Head of Digital Marketing and Public Relations; MVS Pharma GmbH

Contact: mihaela.ahchieva@mvs-pharma.com

For general inquiries: info@mvs-pharma.com

German Version

Entwicklung unter pharmazeutischen Qualitätsstandards

MVS Omega-3 wird unter pharmazeutisch ausgerichteten Qualitätssystemen entwickelt, produziert und verpackt. Dokumentierte und auditierte Prozesse umfassen unter anderem:

• Rohstoffbeschaffung
• Validierung der Verkapselung
• Kontrollierte Lagerbedingungen
• GDP-konforme Transportprozesse

Die Ölqualität wird durch international anerkannte Referenzlabore überprüft; die Herstellung erfolgt unter zertifizierter Qualitätsaufsicht.

Neuer Qualitätsmaßstab

„Unser Ziel war nicht, ein weiteres Omega-3-Produkt zu entwickeln, sondern die Stabilität von Omega-3 grundsätzlich neu zu denken“, erklärt ein Sprecher der MVS Pharma GmbH. „Verbraucher verdienen Transparenz, geprüfte Qualität und Systeme, die Frische vom Herstellungsprozess bis zur Einnahme sichern.“

Durch die Kombination aus hoher Reinheit, Oxidationskontrolle, optimierter Bioverfügbarkeit und innovativer Verpackungstechnologie setzt MVS Omega-3 nach Unternehmensangaben neue Maßstäbe im Bereich der Fischöl-Supplementierung.

Verfügbarkeit

MVS Omega-3 ist ab sofort über die offiziellen Vertriebskanäle der MVS Pharma GmbH erhältlich.

Über MVS Pharma GmbH

Die MVS Pharma GmbH ist ein deutsches Pharma- und Life-Science-Unternehmen mit Fokus auf evidenzbasierte Produktentwicklung, exzellentes Qualitätsmanagement und innovative Formulierungstechnologien. Das Unternehmen steht für Transparenz, Rückverfolgbarkeit und wissenschaftlich fundierte Innovation im Bereich präventiver Gesundheitslösungen.

Pressekontakt:
Media Relations
MVS Pharma GmbH
info@mvs-pharma.com

The post MVS Pharma GmbH Launches MVS Omega-3: A New Standard in Fish Oil Supplementation appeared first on MVS Pharma.